Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
cystic fibrosis
detroit blog main
detroit top stories
fda
gene therapy
indiana blog main
2
×
indiana top stories
life sciences
national
national blog main
national top stories
nestle
2
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
2
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
abbvie
acute myeloid leukemia
aimmune therapeutics
akcea therapeutics
akebia therapeutics
alex pinto
amarin pharma
What
ahead
2
×
bio
roundup
2
×
abbvie’s
asco
biofourmis
branded
bucks
cancer
celebrate
chance
choices
commissioner
consumers
corner
costly
counterweight
day
days
drugs
elevatebio
fda
forward
generic
graft
holiday
labor
looking
medications
people
pharma
rises
summer
supposed
tenure
waning
Language
unset
Current search:
ahead
×
photo
×
" san diego blog main "
×
roundup
×
" indiana blog main "
×
nestle
×
@xconomy.com
4 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More